FindTrial
Sign In

Optimization of polymyxin B dosing regimen in critically ill patients based on therapeutic drug monitoring

Optimization of polymyxin B dosing regimen in critically ill patients based on therapeutic drug monitoring

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062382
Enrollment
Unknown
Registered
2022-08-03
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe infections

Interventions

Observation group:Therapeutic drug monitoring

Sponsors

the Second Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 89 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years; 2. Normative use of polymyxin B for the treatment of multidrug resistant bacterial infections; 3. Consent for polymyxin B blood concentration monitoring.

Exclusion criteria

Exclusion criteria: 1. Patients who refused to participate in the study; 2. Age <18 years; 3. Patients who failed to complete polymyxin treatment.

Design outcomes

Primary

MeasureTime frame
Polymyxin B blood concentrations;—

Countries

China

Contacts

Public ContactZhang Jin
94364391@qq.com+86 13965042141

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026